Medical News

RSS

Forterus signs agreements with J.P. Morgan Chase and other independent investors

Forterus, Inc. today announced that it has signed agreements with J.P. Morgan Chase & Co. and other independent investors to provide financing to qualified consumers seeking behavioral healthcare services.

9 Jun 2010

Resverlogix' RVX-208 increases plasma levels of Apolipoprotein A-I and HDL-cholesterol

Resverlogix is pleased to announce that it has collaborated with the Division of Cardiology at the Research Institute of the McGill University Health Centre (RI of the MUHC), to publish today in the Journal of American College of Cardiology (JACC), a report entitled 'RVX-208 A Small Molecule that Increases Apolipoprotein A-I and High Density Lipoprotein Cholesterol In Vitro and In Vivo'.

9 Jun 2010

NWBT announces release of new detailed report by Pharmaceuticals and Biotech Analyst

Northwest Biotherapeutics, Inc., developer of the DCVax personalized cancer vaccine, today announced the release of a new detailed report by Pharmaceuticals and Biotech Analyst Dr. Navid Malik of the London-based Matrix Group.

9 Jun 2010

Connections project to debate effectiveness of drug and alcohol interventions within criminal justice system

The second annual European gathering of the Connections project, a University of Kent-managed project co-funded by the European Commission Public Health Programme, will debate the ethics, effectiveness and economics of drug and alcohol interventions within the criminal justice system.

9 Jun 2010

Update on Phase II clinical study of CH-4051 in rheumatoid arthritis

Chelsea Therapeutics International, Ltd. announced that during a teleconference yesterday, the U.S. Food and Drug Administration requested that the company delay the initiation of its proposed Phase II clinical study of CH-4051 in rheumatoid arthritis and indicated that the agency is requesting additional detail from the preclinical studies previously submitted as part of the company's investigational new drug application.

9 Jun 2010

Faith-based HIV-prevention program for African-American women and girls

Developing and evaluating a faith-based, HIV-prevention program for African-American mothers and their daughters is the focus of Dr. Chisina Kapungu's $795,000 career development grant from the National Institute of Mental Health.

9 Jun 2010

Human Genome Sciences reports results of mapatumumab Phase 2 trial for multiple myeloma

Human Genome Sciences, Inc. today announced the results of its randomized Phase 2 trial of mapatumumab (HGS-ETR1) in combination with bortezomib (Velcade) in patients with advanced multiple myeloma.

9 Jun 2010

LUMEDX certified as official ACC-NCDR ICD Registry 2.0 software vendor

The American College of Cardiology has certified LUMEDX Corporation--the industry leader in integrated cardiovascular information systems and the number one provider of ACC software--as an official ACC-NCDR ICD Registry 2.0 software vendor. LUMEDX's Export to ICD Registry solution is the latest in a suite of software applications developed to address the growing need for impeccable, accessible cardiovascular data, streamlined clinical workflows and superior data management.

9 Jun 2010

Some commonly used drugs cause bone loss: New research

New research helps to explain why some commonly used drugs come with a serious downside: They up your odds of breaking a bone. The drugs in question, glucocorticoids (e.g. cortisone and prednisone) and the insulin sensitizer rosiglitazone work through entirely different mechanisms as therapies for inflammatory diseases and diabetes respectively, and two studies in the June issue of Cell Metabolism now show that they lead to bone loss in different ways too.

9 Jun 2010

Additional markers of risk for diabetic microvascular complications beyond Hemoglobin A1c needed

The "gold standard" diabetes test, Hemoglobin A1c (A1C), explains much less about the risk of cardiovascular complications in patients with diabetes than originally thought, according to an article in the June 9 issue of the Journal of the American Medical Association (JAMA). The article entitled, "Beyond HbA1c: Need for Additional Markers of Risk for Diabetic Microvascular Complications," was co-authored by Irl Hirsch, M.D., of the University of Washington Medical School (Seattle, WA) and Michael Brownlee, M.D., of the Albert Einstein College of Medicine.

9 Jun 2010

Delaware's first-in-the-nation guidelines for nutrition and physical activity in child care accepted: Study

A study conducted by the nonprofit health research organization Altarum Institute suggests that Delaware's first-in-the-nation guidelines for nutrition and physical activity in child care are broadly accepted by both child care providers and parents, and that challenges to implementing the policies can be overcome with support.

9 Jun 2010

Four-year follow-up results from SPRYCEL Phase 3 study in CML-CP presented at ASCO

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced four-year follow-up results from a Phase 3 randomized, open-label, dose-optimization study of SPRYCEL® (dasatinib) in chronic-phase chronic myeloid leukemia (CML-CP) patients resistant or intolerant to Gleevec®* (imatinib mesylate). At four years, for all patients administered SPRYCEL 100 mg once daily, overall survival was 82% (95% CI: 76%-88%) and progression-free survival was 66% (95% CI: 57%-74%).

9 Jun 2010

Stress-reducing psychological intervention helps increase quality of life among women with breast cancer

Stress-reducing psychological intervention helps to increase survival and quality of life among women with recurrent breast cancer over the long-term, according to results of a Phase III study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

9 Jun 2010

Lapses in infection control common in ambulatory surgical centers

An assessment of nearly 70 ambulatory surgical centers in three states found that lapses in infection control were common, including for practices such as hand hygiene, injection and medication safety and equipment reprocessing, according to a study in the June 9 issue of JAMA.

9 Jun 2010

Patients with BAI can be managed non-operatively with beta-blockade: Researchers

Select patients with blunt aortic injury can be safely managed non-operatively with beta-blockade to lower the heart rate and blood pressure, according to a new study from the 64th Vascular Annual Meeting presented by the Society for Vascular Surgery.

9 Jun 2010

Cycle helmets exude odoriferous oils when cracked

Cycle helmets are available in a wide range of types, including foldable models, models fitted with a flashing rear light or featuring an iPhone display. In future, they will start to smell distinctively if they need to be replaced. A new process causes odoriferous oils to exude from plastic materials if they are cracked.

9 Jun 2010

Purdue University researchers develop potential new tool for medical diagnostics, testing food

Researchers at Purdue University have developed a potential new tool for medical diagnostics, testing food and water for contamination, and crime-scene forensics.

9 Jun 2010

Clinical guidelines for UC emergency medicine physicians

Though guidelines for best treatment practices are common, they are only partially effective without standardized, routine exposure to them in clinical practice, according to a study conducted by University of Cincinnati emergency medicine researchers.

9 Jun 2010

Biofeedback training on MPA decreases performance anxiety, improves performance in musicians

Traditionally, the most successful methods used to combat stage fright have been prescribed medications (beta blockers) and aerobic exercise. In the most recent issue of Biofeedback, researchers studied another technique: the effect of biofeedback training on Musical Performance Anxiety (MPA). MPA is a severe form of stage fright marked by high anxiety levels and impaired performance.

9 Jun 2010

Researchers compare effectiveness of IB and AMP in high-risk patients

Major amputation is often selected over infrainguinal bypass in patients with severe systemic comorbidities because of a presumed decrease in risk of perioperative morbidity and mortality. To investigate this presumption, researchers from the Division of Vascular and Endovascular Surgery at the Brigham and Women's Hospital in Boston undertook a risk-adjusted comparison of early postoperative morbidity and mortality of high-risk patients undergoing infrainguinal bypass and major amputation.

9 Jun 2010

Medical News

Forterus signs agreements with J.P. Morgan Chase and other independent investors

Resverlogix' RVX-208 increases plasma levels of Apolipoprotein A-I and HDL-cholesterol

NWBT announces release of new detailed report by Pharmaceuticals and Biotech Analyst

Connections project to debate effectiveness of drug and alcohol interventions within criminal justice system

Update on Phase II clinical study of CH-4051 in rheumatoid arthritis

Faith-based HIV-prevention program for African-American women and girls

Human Genome Sciences reports results of mapatumumab Phase 2 trial for multiple myeloma

LUMEDX certified as official ACC-NCDR ICD Registry 2.0 software vendor

Some commonly used drugs cause bone loss: New research

Additional markers of risk for diabetic microvascular complications beyond Hemoglobin A1c needed

Delaware's first-in-the-nation guidelines for nutrition and physical activity in child care accepted: Study

Four-year follow-up results from SPRYCEL Phase 3 study in CML-CP presented at ASCO

Stress-reducing psychological intervention helps increase quality of life among women with breast cancer

Lapses in infection control common in ambulatory surgical centers

Patients with BAI can be managed non-operatively with beta-blockade: Researchers

Cycle helmets exude odoriferous oils when cracked

Purdue University researchers develop potential new tool for medical diagnostics, testing food

Clinical guidelines for UC emergency medicine physicians

Biofeedback training on MPA decreases performance anxiety, improves performance in musicians

Researchers compare effectiveness of IB and AMP in high-risk patients

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News